iiinova — where your digital self keeps evolving

Reposted by Shelley Zieroth

iCardio @icardio.bsky.social · 03/11/2025

Join colleagues worldwide in our study on the perception and implementation of #IHD practice guidelines. Your input will help to guide the #iCARDIOAlliance as we develop new, globally relevant IHD guidelines. Survey link: icardioalliance.org @shelleyzieroth.bsky.social #cardiosky #medsky

011

Reposted by Shelley Zieroth

The Canadian Cardiovascular Society @ccs-scc.bsky.social · 20/10/2025

🚨 Just published! This guideline provides multi-disciplinary clinical teams with practical recommendations for SGLT2is, MRAs, ARNI and drugs with GLP-1 receptor agonist activity. Read the guideline here: onlinecjc.ca/article/S082... #Cardiosky #HeartFailure

036

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 12/06/2025

The invisible costs of heart failure: a societal toll academic.oup.com/eurheartj/ad... @escardio.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @erinmichos.bsky.social @drmarthagulati.bsky.social

043

Reposted by Shelley Zieroth

Priyanka Satish @psatishmd.bsky.social · 02/05/2025

Kudos to this expert group on this comprehensive yet realistic guideline document! Love the introduction of recommendations when resources are somewhat or severely limited. #cardiosky #globalcardiology #globalhealth

062

Reposted by Shelley Zieroth

iCardio @icardio.bsky.social · 02/06/2025

Only a few hours left! The iCARDIO Guidelines for CVD in Obesity close for public review today. Help shape global strategies to address this urgent health crisis. Submit feedback now: icardioalliance.org #CVD #Obesity #Cardiology #PublicReview #GlobalHealth @shelleyzieroth.bsky.social

011

Shelley Zieroth @shelleyzieroth.bsky.social · 01/05/2025

Ecstatic to see these rapid HF GL come to open access! >50% of writers outside of Euro+NA with cascading rec's based on availability+accessibility. Global experts bring a concise 28pg simple HF GL!! More @icardio.bsky.social GL on obesity soon on the way. @fpinto1960.bsky.social #medsky #cardiosky

062

Reposted by Shelley Zieroth

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 29/04/2025

Research letter in @jama.com on sema and tirze Rx for obesity in the US The graph goes up and down from shortages mostly interesting race/socioeconomic differences jamanetwork.com/journals/jam... #MedSky

Figure. Prescription Rates of Semaglutide and Tirzepatide for Obesity, Overall and by Race and Ethnicity, Social Vulnerability, and Urbanicity

131

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 18/04/2025

Gaps and Knowledge in the Contemporary Management of Acute Right Ventricular Failure www.ahajournals.org/doi/10.1161/... @ahascience.bsky.social #RVFailure #HeartFailure #CardioEd @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @mmamas1973.bsky.social @mirvz.bsky.social

033

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 13/04/2025

#Aldosterone-targeted therapies: early implementation in resistant #HTN and #CKD Reflecting on the fundamentals and exploring future directions academic.oup.com/eurheartj/ad... #CardioSky @escardio.bsky.social #EHJ @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social

0109

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 10/04/2025

Lower extremity lymphatic flow is associated with diuretic response in acute heart failure In 65 AHF patients, lymphatic flow (via ICG lymphangiography) predicted diuretic response. #AHF #CardioSky #Lymphatics #AHF @shelleyzieroth.bsky.social @escardio.bsky.social @drrajivsankar.bsky.social

165

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 10/04/2025

Efficacy, Safety and Mechanistic Impact of a #HeartFailure Guideline-Directed Medical Therapy Clinic #JACCHF #CardioSky #GDMT www.jacc.org/doi/full/10.... @jimjanuzzi.bsky.social @jaccjournals.bsky.social @drmarthagulati.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social

044

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 08/04/2025

Prognostic value of left atrioventricular coupling index in heart failure In 478 HF patients (LVEF <50%), higher #LACI (≥30.9%) was linked to worse outcomes. academic.oup.com/ehjcimaging/... @escardio.bsky.social @cardioobdoc.bsky.social @vassv.bsky.social @shelleyzieroth.bsky.social

044

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 05/04/2025

Multicentre comparison of various microaxial pump devices as a bridge to durable assist device implantation onlinelibrary.wiley.com/doi/10.1002/... #Impella #CardioSky #CardiogenicShock #LVADs @drrajivsankar.bsky.social @shelleyzieroth.bsky.social @cardioobdoc.bsky.social @hvanspall.bsky.social

035

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 27/03/2025

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does HF With Supranormal EF Exist? Data From the 🇸🇪 #HeartFailure Registry www.ahajournals.org/doi/10.1161/... @ahascience.bsky.social @gbiondizoccai.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social

034

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 23/03/2025

Ventricular arrhythmias in #AHF . A clinical consensus statement of the Association for Acute CardioVascular Care (#ACVC), #EHRA and the #HFA of the @escardio.bsky.social onlinelibrary.wiley.com/doi/full/10.... #CardioSky @novitham.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social

037

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 20/03/2025

Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives A scientific statement of the #HFA of @escardio.bsky.social onlinelibrary.wiley.com/doi/full/10.... @shelleyzieroth.bsky.social @cardioobdoc.bsky.social @drrajivsankar.bsky.social #CardioSky

055

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 20/03/2025

Cardioprotective effects of #semaglutide on isolated human ventricular myocardium onlinelibrary.wiley.com/doi/full/10.... #GLP1RA #CardioSky #EJHF @escardio.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social @vietheartpa.bsky.social

043

Reposted by Shelley Zieroth

Dr Martha Gulati @drmarthagulati.bsky.social · 13/03/2025

Today our opinion piece is in print @usatoday.com NIH cuts will harm women’s heart research. We cannot afford to go backwards. Women’s heart health is not political. @SmidtHeart @WomensHeartCS #savingwomenshearts #womenshearthealth 📎 www.usatoday.com/story/opinio...

28033

Reposted by Shelley Zieroth

Dr Martha Gulati @drmarthagulati.bsky.social · 22/02/2025

Thank you @barbrastreisand.bsky.social for fighting the fight with us #womenshearthealth

0176

Reposted by Shelley Zieroth

Dr Martha Gulati @drmarthagulati.bsky.social · 18/02/2025

Our joint publication with @jcardfail.bsky.social & @ajpcardio.bsky.social is out! Underpinnings of #HeartFailure With Preserved Ejection Fraction in Women - From Prevention to Improving Function #HFpEF #CVPrev #CardioTwitter #womenshearthealth #heartmonth 📎 onlinejcf.com/article/S107...

22312

Reposted by Shelley Zieroth

Women As One @womenasone.bsky.social · 17/02/2025

🌟2025 Mentorship Awards applications are open - please share! Elevate your career with 1-on-1 mentorship, check-ins with global leaders, and impactful scientific projects - all while expanding your professional network. Apply today: womenasone.org/award... #WomenAsOneAwards #CardioSky

044

Reposted by Shelley Zieroth

European Society of Cardiology @escardio.bsky.social · 12/02/2025

Join international experts at #HeartFailure2025! 🌍 Discover cutting-edge science and gain fresh insights to elevate your practice. Register by March 17 to save the most 👉 bit.ly/4hR37FO #CardiologyResearch #HeartFailureResearch

032

Reposted by Shelley Zieroth

Parham Eshtehardi MD @cardioobdoc.bsky.social · 05/02/2025

In a European cohort, lifetime risk of developing HFrEF was greater in men, while women were at greater risk of developing HFpEF. 8 modifiable RFs substantially accounted for developing HF. #CardioSky academic.oup.com/eurheartj/ad... @anastasiasmihaili.bsky.social @vietheartpa.bsky.social

0108

Reposted by Shelley Zieroth

iCardio @icardio.bsky.social · 27/01/2025

We had a great response. Your insights will help to make sure the Guidelines are thorough, accurate, and can be implemented across the globe, regardless of economic setting. Watch the #iCARDIOAlliance website for news on publication. @shelleyzieroth.bsky.social #CardioSky #MedSky #HeartFailure

042

Reposted by Shelley Zieroth

iCardio @icardio.bsky.social · 17/01/2025

The deadline for the Public Review of iCARDIO’s Global #HeartFailure Guidelines is extended to 25 January! Your feedback is critical in shaping the future of heart failure care globally. Don’t wait—participate now. Access the resources here: icardioalliance.org/public-revie... #Healthcare

154

Reposted by Shelley Zieroth

American College of Cardiology @accintouch.bsky.social · 16/01/2025

#ACC25 features 11 learning pathways, each focusing on a different clinical specialty of #CVD. Choose to focus on one clinical area or attend sessions from an array of pathways. 👇 Learn more about the sessions happening in each learning pathway: bit.ly/40iqKzZ #CardioSky #MedSky

046

Reposted by Shelley Zieroth

iCardio @icardio.bsky.social · 14/01/2025

O5 days left! Share your comments now on the draft Global implementation guidelines on Heart Failure of the iCardio Alliance. Download the draft global guidelines & the comment form. All feedback will be reviewed by the Heart Failure Task Force. Website link icardioalliance.org #iCARDIOAlliance

031

Shelley Zieroth @shelleyzieroth.bsky.social · 05/01/2025

💥 Please take this opportunity to comment and contribute to the @icardio.bsky.social Global Implementation #heartfailure Guidelines. Public comments open until Jan 19th!! Go to icardioalliance.org/public-reviews/ @fpinto1960.bsky.social #medsky #cardiosky

icardioalliance.org

Public Reviews – iCARDIO Alliance

023

Reposted by Shelley Zieroth

Dr Anastasia S Mihailidou PhD FAHA FCSANZ FESC @anastasiasmihaili.bsky.social · 28/12/2024

Happy Birthday dear @shelleyzieroth.bsky.social 🤗 Wishing you a great day of celebrations & a super year ahead 🎉🎈🎁🍾 Love catching up with you & fond memories🥂

161

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 27/12/2024

Applying the ‘touch-and-go’ concept to #MRAs : A paradigm shift in routine heart failure management Addressing the barriers: rethinking WRF and #hyperkalaemia onlinelibrary.wiley.com/doi/abs/10.1... @escardio.bsky.social @anastasiasmihaili.bsky.social @shelleyzieroth.bsky.social

053

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 18/12/2024

We treat patients, not lab results” can be augmented to “We treat patients, not P values.” evidence.nejm.org/doi/full/10.... #MedSky @nejm.org @drmarthagulati.bsky.social @mmamas1973.bsky.social @cardioobdoc.bsky.social @shelleyzieroth.bsky.social

1126

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 18/12/2024

#Patiromer for #HeartFailure Medication Optimization in Patients With Current or Past #Hyperkalemia: #DIAMOND Subanalysis www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social @shelleyzieroth.bsky.social @jgrapsa.bsky.social @erinmichos.bsky.social @vietheartpa.bsky.social

076

Reposted by Shelley Zieroth

Parham Eshtehardi MD @cardioobdoc.bsky.social · 17/12/2024

Prognostic impact of inducible ischaemia in ischaemic LV dysfunction: REVIVED-BCIS2 trial #CardioSky #MedSky @escardio.bsky.social @robmentz.bsky.social @shelleyzieroth.bsky.social @anastasiasmihaili.bsky.social @dranulala.bsky.social @dreprime.bsky.social academic.oup.com/eurheartj/ad...

064

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 15/12/2024

Results of the biomarker substudy of Relaxin in #AHF-2 (#RELAX-AHF-2) In this substudy, serelaxin decreased plasma concentrations of cardiac, renal and hepatic injury markers. onlinelibrary.wiley.com/doi/full/10.... #EJHF @escardio.bsky.social @shelleyzieroth.bsky.social @noshreza.bsky.social

021

Reposted by Shelley Zieroth

European Society of Cardiology @escardio.bsky.social · 12/12/2024

Hello #Medsky #CardioSky The ESC is now on Bluesky🙂 We aim to bring you here the latest in cutting-edge cardiovascular science, from all ESC resources, including the successful #ESCTVToday CV news programme. We equally aim to bring you updates from all ESC communities and to bring you altogether.

36419

Reposted by Shelley Zieroth

Dr Martha Gulati @drmarthagulati.bsky.social · 11/12/2024

Today has been a magical, special day. I had the honour of representing Cedars Sinai & presenting at the White House on where we need to go in Women’s Cardiovascular Health. I am still pinching myself. How was this real???? #savingwomenshearts #womenscardiovascularhealth @smidtheart.bsky.social

6559

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 11/12/2024

Machine learning approach to identify phenotypes in patients with ischaemic #HFrEF This clustering analysis reveals distinct risk subgroups in the heterogeneous array of ischaemic HFrEF patients. onlinelibrary.wiley.com/doi/full/10.... @escardio.bsky.social @shelleyzieroth.bsky.social

131

Reposted by Shelley Zieroth

Brendon Neuen @brendonneuen.bsky.social · 12/12/2024

Prevent kidney failure to reduce carbon emissions ♻️ 🍃 🏭 Our new analysis of CREDENCE assessing environmental impacts from ⬇️ hospitalisations & dialysis 🏥 with SGLT2i SGLT2i ⬇️ greenhouse gas emissions from inpatient bed days & dialysis by 20% (39 kg CO2e per yr) www.thelancet.com/journals/lan...

0127

Reposted by Shelley Zieroth

Robert Mentz, MD @robmentz.bsky.social · 10/12/2024

Lots of learning and connecting at CVCT 2024 - always a good time #JCFfam #cardioSky @noshreza.bsky.social @shelleyzieroth.bsky.social @jozinetm.bsky.social

1183

Reposted by Shelley Zieroth

Dr Rajiv Sankaranarayanan @drrajivsankar.bsky.social · 08/12/2024

www.tandfonline.com/doi/full/10.... Review of “Relaxin agonists under preclinical & early clinical investigation for treatment of #heartfailure “ by @liverpoolccs.bsky.social cardiology trainee #AshwinAjay et al @shelleyzieroth.bsky.social @hancardiomd.bsky.social @robmentz.bsky.social #cardiosky

082

Reposted by Shelley Zieroth

Jonathan Davis, MD, MPHS @jonathandavishf.bsky.social · 06/12/2024

Check out our extensive review on contemporary role for ICD in era of improved GDMT led by Amin Yehya, MD. We also propose pragmatic guidance for shared decision-making discussions for primary ICD implantation. @jaccjournals.bsky.social www.sciencedirect.com/science/arti...

sciencedirect.com

Revisiting ICD Therapy for Primary Prevention in Patients With Heart Failure and Reduced Ejection Fraction

Implantable cardioverter-defibrillators (ICDs) are recommended to reduce the risk of sudden cardiac death (SCD) in patients with heart failure with re…

076

Reposted by Shelley Zieroth

Novi Yanti Sari @novitham.bsky.social · 05/12/2024

🚨🚨Call for Science for #HeartFailure2025 is now OPEN!🫀 Present your work📚, network with experts🫀& compete at the investigator awards for a chance to win €1,000 + free reg for finalists👌 🔹Abstracts: 9 Jan 🔹Clinical Cases: 21 Jan 🔹Late-Breaking: 14 Jan-14 Mar ➡️ www.escardio.org/Congresses-E...

1118

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 04/12/2024

Discontinuation and reinitiation of #MRAs in patients with heart failure and reduced ejection fraction onlinelibrary.wiley.com/doi/full/10.... #EJHF @cardioobdoc.bsky.social @shelleyzieroth.bsky.social @drrajivsankar.bsky.social @anastasiasmihaili.bsky.social

064

Reposted by Shelley Zieroth

Henry Han @hancardiomd.bsky.social · 04/12/2024

#Diuretic efficiency of a single dose of SC Vs oral #furosemide after heart failure hospitalization across diuretic resistance strata: A pilot RCT onlinelibrary.wiley.com/doi/full/10.... @shelleyzieroth.bsky.social @novitham.bsky.social @anastasiasmihaili.bsky.social @noshreza.bsky.social

044

Reposted by Shelley Zieroth

Novi Yanti Sari @novitham.bsky.social · 02/12/2024

Analysis of 1078 pts in #STRONG_HF: 📍Rapid #GDMT uptitration (~80% dose by day 90) is safe, feasible & ⬇️#HF readmissions/mortality in pts w/wo #AFib 📍#AFib shouldn’t be a barrier, all #HF pts deserve optimal care #GDMTworks 🔗 www.jacc.org/doi/full/10.... #JACCHF #Epeeps @jaccjournals.bsky.social

1128